发明名称 UROKINASE INHIBITORS
摘要 The invention relates to the compounds of general formula (I), that are present with respect to R<1> as racemates as well as L- or D-configured compounds and as E/Z mixtures as well as E or Z isomers and in which the various symbols are defined as in the description and the claims, as well as to the salts thereof, for use as therapeutic agents and for diagnostic purposes. The inventive compounds can be processed to medicaments or to diagnostic agents that are used for the diagnosis, therapy and prevention of urokinase- or urokinase-receptor associated diseases, for example for the treatment of tumors. The compounds are highly efficient in inhibiting growth and/or spread of malign tumors, for example tumor spread of pancreatic cancer, tumor growth of breast cancer and the formation of tumor metastases. The compounds of formula (I) and the salts thereof can be produced by conventional methods.
申请公布号 WO02074756(A3) 申请公布日期 2002.12.12
申请号 WO2002CH00162 申请日期 2002.03.19
申请人 PENTAPHARM AG;ZIEGLER, HUGO 发明人 ZIEGLER, HUGO
分类号 C07D295/20;A61K31/495;A61K31/4965;A61K45/00;A61P17/00;A61P35/00;A61P35/04;A61P43/00;C07D295/215 主分类号 C07D295/20
代理机构 代理人
主权项
地址